Ad
related to: cooperative research and development agreement crada
Search results
Results from the WOW.Com Content Network
In the United States, a cooperative research and development agreement (CRADA or CRDA) is an agreement between a government agency and another government agency, a private company, non-profit, or university to work together on research and development.
Federal Technology Transfer Act of 1986; Long title: An Act to amend the Stevenson-Wydler Technology Innovation Act of 1980 to promote technology transfer by authorizing Government-operated laboratories to enter into cooperative research agreements and by establishing a Federal Laboratory Consortium for Technology Transfer within the National Science Foundation, and for other purposes.
CEL-SCI Announces Cooperative Research and Development Agreement (CRADA) for Multikine with US Navy VIENNA, Va.--(BUSINESS WIRE)-- CEL-SCI Corporation (NYSE MKT:CVM) today announced that it has ...
In 2024, it was awarded a contract by the Air Force Research Laboratory and AFWERX to develop hybrid engine technology for hypersonic missiles. [2] [6] A Cooperative Research and Development Agreement (CRADA) with the U.S. Army Combat Capabilities Development Command Aviation and Missile Center (DEVCOM AvMC) was signed in 2024. [7]
NASA said that under a Cooperative Research and Development Agreement, the space agency and its industry partner will contribute services, technology and hardware to the collaboration. The VIPER ...
Leader in performance and reliability GaN development. University Partners. ... (ARL) Cooperative Research and Development Agreement (CRADA) to jointly develop advanced GaN circuits.
This initiative is designed to provide clinicians with better data about how an individual patient may respond to treatment. The company also signed a Cooperative Research and Development Agreement (CRADA) with the U.S. Food and Drug Administration to advance and qualify its Human Emulation System to meet regulatory evaluation for product ...
In January, it was announced that Kite Pharma has entered into a Cooperative Research and Development Agreement (CRADA) with the NCI for the research and clinical development of a fully human anti-CD19 chimeric antigen receptor (CAR) product candidate for the treatment of B-cell lymphomas and leukemia. [29]
Ad
related to: cooperative research and development agreement crada